The circumferential resection margin in rectal carcinoma surgery

Techniques in Coloproctology

Volumn 9, Issue 3, 2005, Pages 193-200

  Hermanek, P ^a   Junginger, T ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Circumferential resection margin; Local recurrence; Neoadjuvant therapy; Rectal carcinoma; Survival; Total mesorectal excision

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PROGNOSIS; RECTUM CARCINOMA; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 28844474532     PISSN: 11236337     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10151-005-0226-1     Document Type: Review

References (74)

1. Hermanek P (2000) What can the pathologist tell the surgeon about rectal cancer resection? In: Scholefield JH (ed) Challenges in colorectal cancer. Blackwell Science, Oxford, pp 80-90
2. Hermanek P (1983) Pathohistologische Begutachtung von Tumoren. Perimed, Erlangen
3. Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet ii:996-999
4. Quirke P, Dixon MF (1988) The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorect Dis 3:127-131
5. Quirke P, Scott N (1992) The pathologist's role in the assessment of local recurrence in rectal carcinomas. Surg Oncol Clin N Am 1:1-17
6. Zarbo RJ (1992) Interinstitutional assessment of colorectal carcinoma surgical report adequacy. Arch Pathol Lab Med 116:1113-1119
7. Bull AD, Biffin AHB, Mella J et al (1997) Colorectal cancer pathology reporting: a regional audit. J Clin Pathol 50:138-142
8. Compton CC (2003) Colorectal carcnoma: diagnostic, prognostic, and molecular features. Mod Pathol 16:376-388
9. Stocchi L, Nelson H, Sargent DJ et al (2001) Impact of surgical and pathologic variables in rectal cancer: a United States Community and Cooperative Group report. J Clin Oncol 19:3895-3902
10. Rigby K, Brown SR, Lakin G et al (1999) The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Edinb 81:401-403
11. ACO (Arbeitsgemeinschaft für Chirurgische Onkologie der Österreichischen Gesellschaft für Chirurgie) (1995) Consenus-Bericht Kolorektalkarzinom (Smola MG, Hrsg). ACO, Graz
12. Deutsche Krebsgesellschaft (1995) Diagnostische Standards. Lungen-, Magen-, Pankreas- und kolorektales Karzinom (Hermanek P, Hrsg). W Zuckschwerdt, München Bern Wien New York
13. Japanese Society for Cancer of the Colon and Rectum (1997) Japanese classification of colorectal carcinoma, first English edition. Kanehare, Tokyo
14. Soreide O, Norstein J, Fielding LP, Silen W (1997) International standardization and documentation of the treatment of rectal cancer. In: Soreide O, Norstein J (eds) Rectal cancer surgery. Optimisation - standardisation - documentation. Springer, Berlin Heidelberg New York, pp 405-445
15. Minsky BD, Cola L, Haller D et al (1998) Treatment systems guidelines for primary rectal cancer from the 1996 patterns of care study. Int J Radiat Oncol Biol Phys 41:21-27
16. NHMRC (National Health and Medical Research Council) (1999) The prevention, early detection and management of colorectal cancer. Clinical practice guidelines. Commonwealth of Australia, Canberra
17. Compton CC, for the Members of the Cancer Committee, College of American Pathologists (2000) Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix. A basis for checklists. Arch Pathol Lab Med 124:1016-1025
18. Royal College of Pathologists (1992) Minimum dataset for colorectal cancer. (Quirke P, Williams GT, Coordinators). www.rcpath.org/resourced/pdf/ colorectalcancer.pdf
19. th edn. In: Green FL, Page DL, Fleming IF et al (eds) Springer, Berlin Heidelberg New York
20. Hermanek P (2000) Pathology of colorectal cancer. In: Bleiberg H, Kemeny N, Rougier P, Wilke H (eds) Colorectal cancer. A clinical guide to therapy. Martin Dunitz, London, pp 55-72
21. SIGN (Scottish Intercollegiate Guidelines Network) (2003) Management of colorectal cancer. A national clinical guideline. SIGN, Royal College of Physicians, Edinburgh
22. Berufsverband Deutscher Pathologen und Deutsche Gesellschaft für Pathologie (2005) Empfehlungen Pathologische Diagnostik des kolorektalen Karzinoms. Berufsverband Deutscher Pathologen, Gelsenkirchen
23. Hermanek P, Wittekind C (1994) The pathologist and the residual tumor (R) classification. Path Res Pract 190:115-123
24. th edn. In: Sobin LH, Wittekind CH (eds) Wiley, New York
25. Birbeck KF, Macklin CP, Tiffin NJ et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235:449-457
26. Nagtegaal ID, Marijnen CAM, Kranenbarg EK et al (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Am J Surg Pathol 26:350-357
27. Quirke P (1997) Limitations of existing systems of staging for rectal cancer: the forgotten margin. In: Soreide P, Norstein J (eds) Rectal cancer surgery. Optimisation - standardisation - documentation. Springer, Berlin Heidelberg New York, pp 63-81
28. Daniels IR and the MERCURY Study Steering Committee (2002) Final proctol of the Magnetic Resonance Imaging and Rectal Cancer European Equivalence Study (MERCURY). Pelican Cancer Foundation, Basingstoke
29. Ng IOL, Luk ISC, Yuen ST et al (1993) Surgical lateral clearance in resected rectal carcinomas. Cancer 71:1972-1976
30. Adam IJ, Mohamdee MO, Martin IG et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707-711
31. De Haas-Kock DFM, Baeten CGMI, Jager JJ (1996) Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 83:781-785
32. Cawthon SJ, Parums DV, Gibbs NM et al (1990) Extent of mesorectal spread and involvement of lateral resection margins as prognostic factors after surgery for rectal cancer. Lancet 335:1055-1059
33. Bernstein MA, Amarnath B, Weiss EG et al (1998) Total mesorectal excision without adjuvant therapy for local control of rectal cancer. A North American experience. Tech Coloproctol 2:11-15
34. Wibe A, Syse A, Andersen E et al (2004) Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs abdominoperineal resection. Dis Colon Rectum 47:48-58
35. Hermanek P, Hermanek P Jr, Hohenberger W et al (2003) The pathological assessment of mesorectal excision - implications for further treatment and quality assessment. Int J Colorect Dis 18:335-341
36. Maugham NJ, Quirke P (2003) Modern managment of colorectal cancer - a pathologist's view. Scand J Surg 92:11-19
37. Nagtegaal ID, van de Velde CHJ, van der Worp E et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729-1734
38. Hall NR, Finan PJ, Al-Jaberi T et al (1998) Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Dis Colon Rectum 41:979-983
39. Wibe A, Rendedal PR, Svensson E et al, on behalf of the Norwegian Rectal Cancer Group (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89:327-334
40. Flor B, Garcia-Granero E, Cervantes A et al (2004) Prognostic impact of the circumferential margin after TME without preoperative chemoradiation on local recurrence of rectal cancer. Colorect Dis 4[Suppl 2]:46 (abstract)
41. Grabbe E, Lierse W, Winkler R (1983) The perirectal fascia: morphology and use in staging of rectal carcinoma. Radiology 149:241-246
42. Nishioka T, Shimizu T, Shirato H et al (1993) Relation between preoperative CT findings in rectal cancer and local recurrence rate. A pilot study. Acta Oncol 32:555-558
43. Brown G, Richards CJ, Newcombe RG et al (1999) Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 211:215-222
44. Stoker J, Rociu E, Wiersma T, Lameris J (2000) Imaging of anorectal disease. Br J Surg 87:10-27
45. Bissett IP, Fernando CC, Hough DM et al (2001) Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum 44:259-265
46. Botterill ID, Blunt DM, Quirke P et al (2001) Evaluation of the role of preoperative magnetic resonance imaging in the managment of rectal cancer. Colorect Dis 3:295-303
47. Beets-Tan RGH (2003) MRI in rectal cancer: the T stage and circumferential margin. Colorectal Dis 5:392-395
48. Brown G, Richards CJ, Bourne MW et al (2003) Morphologic predictors of lymph node status in rectal cancer with use of high spatial resolution. MR imaging with histopathologic comparison. Radiology 227:371-377
49. Brown G, Radcliffe AG, Newcombe RG et al (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90:355-364
50. Mathur P, Smith JJ, Rasey C et al (2003) Comparison of CT and MRI in the preoperative staging of rectal adenocarcinoma and prediction of circumferential resection margin involvement by MRI. Colorect Dis 5:396-401
51. Martling A, Holm T, Bremmer S et al (2003) Prognostic value of preoperative magnetic resonance imaging of the pelvis in rectal cancer. Br J Surg 90:1422-1426
52. Branagan G, Chave H, Fuller C et al (2004) Can magnetic resonance imaging predict circumferential margins and TNM stage in rectal cancer? Dis Colon Rectum 47:1317-1322
53. Winterbottom A, Shah P, Foster M et al (2004) Is pre-operative MRI mandatory for staging in rectal cancer? Colorect Dis 6[Suppl 2]:58 (abstract)
54. Pahlman L (2000) Neoadjuvant and adjuvant radio- and radiochemotherapy of rectal carcinoma. Int J Colorect Dis 15:1-8
55. Grann A, Feng C, Wong D et al (2001) Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 49:987-995
56. Glimelius B, Grönberg H, Järhult J et al (2003) A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 42:476-492
57. Minsky BD (2003) Adjuvant therapy for rectal cancer - the transatlantic view. Colorect Dis 5:416-422
58. Simunovic M, Sexton R, Rempel E et al (2003) Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Br J Surg 90:999-1003
59. Minsky BD (2004) Combined modality therapy of resectable rectal cancer: current approaches. Tech Coloproctol 8:67-76
60. Daniels JR, Moran BJ, Heald RJ (2004) Surgery alone: is total mesorectal excision sufficient for rectal cancer? In: Wiegel T, Höcht S, Sternemann M, Buhr HJ, Hinkelbein W (eds) Controversies in gastrointestinal tumor therapy. Karger, Basel, pp 28-36
61. Read TE, Andujar JE, Caushaj PF et al (2004) Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 47:825-831
62. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2004) Sphincter preservation following radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventional radiochemotherapy. Radiother Oncol 72:15-24
63. Chari RS, Tyler DS, Anscher MS et al (1995) Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 221:778-787
64. Meade PG, Blatchford GJ, Thorson AG et al (1995) Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer. Am J Surg 170:609-613
65. Stryker SJ, Kiel KD, Rademaker A et al (1996) Preoperative "chemoradiation" for stages II and III rectal carcinoma. Arch Surg 131:514-519
66. Burke SJ, Percarpio BA, Knight DC, Kwasnik EM (1998) Combined preoperative radiation and mitomycin/5-fluorouracil treatment for locally advanced rectal adenocarcinoma. J Am Coll Surg 187:164-170
67. Luna-Pérez P, Trejo-Validivia B, Labastida A et al (1999) Prognostic factors in patients with locally advanced rectal adenocarcinomas treated with preoperative radiotherapy and surgery. World J Surg 23:1069-1075
68. Bossett JF, Magnin V, Maingon P et al (2000) Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiol Oncol Biol Phys 46:323-327
69. Mohiuddin M, Hayne M, Regine WF et al (2000) Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancer. Int J Radiat Oncol Biol Phys 48:1075-1080
70. Metha VK, Cho J, Ford JM et al (2001) Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum 44:52-58
71. Rullier E, Goffre B, Bonnel C et al (2001) Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 234:633-640
72. Theodoropoulos G, Wise WE, Padmanat A et al (2002) T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45:895-903
73. Valentini V, Coco C, Picciocchi A et al (2002) Does down-staging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53:664-674
74. Bedrosian I, Rodriguez-Bigas MA, Feig B et al (2004) Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg 8:56-63